Logo

Next-Generation Sequencing

The latest news on next-generation sequencing.

PlumCare RWE Taps Lifebit to Scale Rady-Backed Newborn Sequencing Screening Program in Greece

Lifebit will help PlumCare RWE connect data from BeginNGS Greece to global research cohorts as the program moves past its pilot phase.

Labcorp, VieCure Collaborate on NGS, Software for Cancer Diagnosis

Startup oncology bioinformatics firm VieCure expects this collaboration to bring precision oncology diagnostics and treatment to more community clinics.

Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug

The companies will develop the FoundationOne CDx test as a companion diagnostic for Boehringer Ingelheim's BI 907828 in the US, Japan, and EU.

Element Biosciences Points to First Wave of Customer Data at JP Morgan Conference

The San Diego-based sequencing instrument maker highlighted data from three customers: the University of California, San Diego; Gencove; and Qiagen.

Sequencing Instrument Launches in 2022 Portend Heated Competition
Premium

Customers are feeling euphoric, but sequencing firms face a number of headaches including competitive pressure and global macroeconomic concerns.

Jan 4, 2023

Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements
Premium

Jan 4, 2023

Agilent Technologies Acquires NGS Target Enrichment Firm Avida Biomed

Dec 19, 2022

MGI Tech Heads Full Steam Into US Market Despite Data Security Accusations, Image Problems
Premium

Dec 16, 2022

EU Awards €4.8M to Support Transition of NGS Workflows to Clinical Settings
Premium

Nov 30, 2022

Bladder Cancer Genomic Landscape Study Aims to Engender New Biomarker-Guided Therapies
Premium

Nov 30, 2022

Envisagenics, Bristol Myers Squibb Partner to ID Cancer Therapy Alternative Splice Targets

Nov 17, 2022

Biomarker Predicts Immunotherapy Benefit in Head and Neck Cancer but Commercial Path Unclear
Premium

Nov 17, 2022

Asa Ren, G42 Healthcare Partner to Promote Genomics, Bioinformatics in Indonesia

Nov 16, 2022

Genome Insight, Seoul National University Hospital Collaborate on WGS Study of Pediatric Cancer Dx

Nov 11, 2022

RevoluGen, Tecan Ink Deal for Automated High Molecular Weight DNA Extraction Tech

Nov 10, 2022

Arima Genomics Inks Distribution Deals in Asia-Pacific Region

Nov 8, 2022

Singular Genomics Inks Sample Prep Partnerships With Paragon Genomics, Claret Bioscience; Reports Q3

Oct 31, 2022

Beckman Coulter Life Sciences, Pillar Biosciences Partner to Develop NGS Solutions

Oct 28, 2022

Illumina Shares Data on Complete Long Read Tech, Stays Mum on Technical Details
Premium

Oct 19, 2022

MDIC, Horizon Discovery Partner on Reference Samples for NGS-Based Cancer Tests

Oct 18, 2022

Real-Time Surveillance Sequencing Shows Promise for Hospital Outbreak Detection, Prevention
Premium

Oct 18, 2022

Illumina, GenoScreen Partner to Comarket Genomic Testing for Multidrug-Resistant TB

Oct 13, 2022

Study Affirms Platelet RNA's Diagnostic Potential for Early- and Late-Stage Cancer Detection
Premium

Oct 11, 2022

Intermountain Forensics Partners with Astrea Forensics to Validate Sample Prep Technology

Oct 7, 2022

Environmental Genomics Firm eDNAtec Harnesses NGS for Biodiversity Surveillance
Premium

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.